Saturday, September 10, 2011

Check your stars to make money on stocks

Astrology is a sure testing stone to see  if you are destined to make money on stocks, or lose..
My research over the past 15 years shows you need the following star combinations to win..
You need planets in 6th House, the house for winning in competition, an effective 3rd House, house of
initiative and action, 5th House, the mental house of an active mental composition,
and connection of all these to the house of 11th, the house of gains, and also 2nd house, another
house for gasins.
While your basic horoscope must indicate these, you should also be running the  Dasa, Bhukti and Anthara
related to the above, and then, and then alone, can you make money, when transits also favour.
So Ideally one could check out if you are destined to make money through trading.
Send me the details of your Birth date, time of birth, Place of birth and I shall tell you
for free if you are destined to make money trading. Send your mails to seshadri9@gmail.com

Sunday, January 17, 2010

Banking stocks exhibit no strength to move up; they are more or less flatish.
And it is a good time to review the returns you have had on your banking stocks, and restructure the portion alloted to banks.
Auto sector has continued to do well. With auto sales doing well in Dec, this segment would get investment attention.
Cement stocks are edging up on the back of strong economic growth.
Engineering stocks like Bhel and Larsen are flattish.
IT sector stocks have posted steady gain, and the latest results confirm the confidence of those who invested here.
In capital goods sector Areva is trying to move up after its recent downturn.
BEML is reaching upwards and it is time to review the potential to 1800.
Ditto Bharat Bijlee.
Everest Canto is another stock worth researching.
Technically it may be time to book profit at Havells.
FMCG stocks are lame, and that is not surprising what with cost of inputs moving up. One could do fund reallocation out of here.
In the pharma segment Sterling Biotech is looking up.